Literature DB >> 11707778

Novel NG36/G9a gene products encoded within the human and mouse MHC class III regions.

S E Brown1, R D Campbell, C M Sanderson.   

Abstract

Previous annotation of the Class III region of the human Major Histocompatibility Complex (MHC) depicts NG36 as an independent gene, which lies immediately centromeric to the G9a gene. However, data presented in this report show that in human and mouse cells the NG36 and G9a genes are predominantly expressed within a single approximately 3.9-kbp transcript. Thus, the human NG36/G9a gene contains 28 exons (4 exons from the NG36 gene and 24 exons from the G9a gene), spans 17.938 kb, and encodes a 1210-amino acid polypeptide. In addition, a splice variant (NG36G9a-SPI), which lacks exon 10, was found to be coexpressed together with the full-length NG36/G9a transcript in both human and mouse cells. To aid functional characterization of the novel NG36/G9a gene-product, T7-epitope-tagged versions of the complete NG36/G9a protein or the G9a region alone (amino acids 210 to 1210) was transiently expressed in mammalian cells. Surprisingly, the sub-cellular distribution of the NG36/G9a-T7 and G9a-T7 proteins was found to be quite distinct. Whereas the G9a-T7 protein was observed in both the cytoplasm and the nucleus, the NG36/G9a-T7 protein was extensively concentrated within the nucleus. Also, the G9a-T7 protein frequently appeared marginalized at the nuclear periphery, while the NG36/G9a-T7 protein was generally found throughout the nucleoplasm. As such, it would appear that the NG36 domain plays a key role in controlling the sub-cellular distribution of the NG36/G9a protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707778     DOI: 10.1007/s00335-001-3029-3

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  24 in total

Review 1.  A drive in SUVs: From development to disease.

Authors:  Vinay Kumar Rao; Ananya Pal; Reshma Taneja
Journal:  Epigenetics       Date:  2017-01-20       Impact factor: 4.528

Review 2.  G9a, a multipotent regulator of gene expression.

Authors:  Shilpa Rani Shankar; Avinash G Bahirvani; Vinay Kumar Rao; Narendra Bharathy; Jin Rong Ow; Reshma Taneja
Journal:  Epigenetics       Date:  2012-12-20       Impact factor: 4.528

3.  Histone methylation, alternative splicing and neuronal differentiation.

Authors:  Ana Fiszbein; Alberto R Kornblihtt
Journal:  Neurogenesis (Austin)       Date:  2016-06-23

Review 4.  Critical roles of protein methyltransferases and demethylases in the regulation of embryonic stem cell fate.

Authors:  Theodore Vougiouklakis; Yusuke Nakamura; Vassiliki Saloura
Journal:  Epigenetics       Date:  2018-01-16       Impact factor: 4.528

Review 5.  Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders.

Authors:  Robert S Porter; Farris Jaamour; Shigeki Iwase
Journal:  Mol Cell Neurosci       Date:  2017-12-15       Impact factor: 4.314

6.  The expanding role of the Ehmt2/G9a complex in neurodevelopment.

Authors:  Steven J Deimling; Jonathan B Olsen; Vincent Tropepe
Journal:  Neurogenesis (Austin)       Date:  2017-05-02

7.  Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression.

Authors:  Konstantinos Boulias; Iannis Talianidis
Journal:  Nucleic Acids Res       Date:  2004-11-18       Impact factor: 16.971

8.  Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy.

Authors:  Sanjib Chowdhury; Sudhakar Ammanamanchi; Gillian M Howell
Journal:  Mol Cell Pharmacol       Date:  2009-01-01

9.  G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis.

Authors:  Makoto Tachibana; Kenji Sugimoto; Masami Nozaki; Jun Ueda; Tsutomu Ohta; Misao Ohki; Mikiko Fukuda; Naoki Takeda; Hiroyuki Niida; Hiroyuki Kato; Yoichi Shinkai
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

10.  Human EHMT2/G9a activates p53 through methylation-independent mechanism.

Authors:  M Rada; E Vasileva; L Lezina; D Marouco; A V Antonov; S Macip; G Melino; N A Barlev
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.